Search
Compass Pathways PLC
CMPSAdd to Watchlist
11.000USD
+0.150+1.38%
Market hours （ET）Quotes delayed by 15 min
680.73MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
17
analysts
Buy
Current Rating
22.861
Target Price
+103.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Compass Pathways PLC
CMPS
17
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
26
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Compass Pathways PLC's price target?
Analysts forecast that Compass Pathways PLC's price target is USD 13.00, with the highest forecast at USD 40.00 and the lowest forecast at USD 6.00.
How have Compass Pathways PLCCMPS's recent earnings per share performed?
The market expectation was USD 0.83, while Compass Pathways PLCCMPS's earnings per share (EPS) for the previous quarter was USD -0.98. EPS for the next quarter is expected at USD -0.40.
What is the analyst rating for Compass Pathways PLC?
Based on the ratings of Compass Pathways PLC's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.